These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 29618011)

  • 21. The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome.
    Raygan F; Rezavandi Z; Dadkhah Tehrani S; Farrokhian A; Asemi Z
    Eur J Nutr; 2016 Dec; 55(8):2357-2364. PubMed ID: 26385228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Text messaging (SMS) as a tool to facilitate weight loss and prevent metabolic deterioration in clinically healthy overweight and obese subjects: a randomised controlled trial.
    Silina V; Tessma MK; Senkane S; Krievina G; Bahs G
    Scand J Prim Health Care; 2017 Sep; 35(3):262-270. PubMed ID: 28812403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal factor analysis reveals a distinct clustering of cardiometabolic improvements during intensive, short-term dietary and exercise intervention in obese children and adolescents.
    Hobkirk JP; King RF; Gately P; Pemberton P; Smith A; Barth JH; Carroll S
    Metab Syndr Relat Disord; 2012 Feb; 10(1):20-5. PubMed ID: 21936669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial.
    Chanoine JP; Hampl S; Jensen C; Boldrin M; Hauptman J
    JAMA; 2005 Jun; 293(23):2873-83. PubMed ID: 15956632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of intramyocellular lipids during hypoglycemia in patients with intensively treated type 1 diabetes.
    Bernroider E; Brehm A; Krssak M; Anderwald C; Trajanoski Z; Cline G; Shulman GI; Roden M
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5559-65. PubMed ID: 15998784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men.
    Pasquali R; Casimirri F; De Iasio R; Mesini P; Boschi S; Chierici R; Flamia R; Biscotti M; Vicennati V
    J Clin Endocrinol Metab; 1995 Feb; 80(2):654-8. PubMed ID: 7852532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of gender on lipid-induced insulin resistance in obese subjects.
    Vistisen B; Hellgren LI; Vadset T; Scheede-Bergdahl C; Helge JW; Dela F; Stallknecht B
    Eur J Endocrinol; 2008 Jan; 158(1):61-8. PubMed ID: 18166818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
    Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF
    Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of supramaximal exercise training on metabolic outcomes in obese adults.
    Jabbour G; Mauriege P; Joanisse D; Iancu HD
    J Sports Sci; 2017 Oct; 35(20):1975-1981. PubMed ID: 27748154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
    Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
    Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of whole body and regional lipolysis by insulin: effects of obesity and exercise.
    Hickner RC; Racette SB; Binder EF; Fisher JS; Kohrt WM
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3886-95. PubMed ID: 10566624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
    Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose-lowering therapies including insulin.
    Jazet IM; Pijl H; Frölich M; Romijn JA; Meinders AE
    Metabolism; 2005 Jun; 54(6):705-12. PubMed ID: 15931603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial.
    van Raalte DH; Brands M; van der Zijl NJ; Muskiet MH; Pouwels PJ; Ackermans MT; Sauerwein HP; Serlie MJ; Diamant M
    Diabetologia; 2011 Aug; 54(8):2103-12. PubMed ID: 21562755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of obesity and distribution of obesity with glucose tolerance and cardiovascular risk factors in the elderly.
    Mykkänen L; Laakso M; Pyörälä K
    Int J Obes Relat Metab Disord; 1992 Sep; 16(9):695-704. PubMed ID: 1328093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats.
    Cefalu WT; Wang ZQ; Zhang XH; Baldor LC; Russell JC
    J Nutr; 2002 Jun; 132(6):1107-14. PubMed ID: 12042418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of insulin resistance by diazoxide in obese Zucker rats.
    Alemzadeh R; Slonim AE; Zdanowicz MM; Maturo J
    Endocrinology; 1993 Aug; 133(2):705-12. PubMed ID: 8344209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The osteoblast: Linking glucocorticoid-induced osteoporosis and hyperglycaemia? A post-hoc analysis of a randomised clinical trial.
    van Bommel EJM; de Jongh RT; Brands M; Heijboer AC; den Heijer M; Serlie MJ; van Raalte DH
    Bone; 2018 Jul; 112():173-176. PubMed ID: 29729427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.